IL33 and glioma: Activation of the JNK pathway was observed also in glioma, where IL-33 and its receptor IL-1RL1 were found overexpressed and were associated with increased cell migration, invasion, epithelial-mesenchymal transition, stemness features and poor patient survival (Lin et al. 2020).